NIH-funded research R01 grant

Understanding how brain injuries in preterm infants affect development

Official title: Overcoming the Inhibitory Neurovascular Niche in Preterm Infant Brain Injury

Funded at University of California, San Francisco · NIH-11070396 · Data updated 2026-11-12

This study is looking at how bleeding in the brain affects the brain development of preterm babies, and it aims to find ways to help prevent problems with their growth and learning by understanding a protein called fibrinogen.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California, San Francisco
NIH-funded
Lab location1 site (San Francisco, United States)
Project startApril 1, 2023
Project endFebruary 29, 2028
Funding year2025
Award (this year)$507,079
NIH project number5R01NS126498-03
Project IDNIH-11070396 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are preterm infants who are at risk for central nervous system hemorrhage.

Less likely to help

Patients who are not preterm or do not have a history of brain hemorrhage may not benefit from this research.

What this research studies

This research investigates the impact of central nervous system hemorrhage on the brain development of preterm infants. It focuses on understanding the molecular signals that disrupt cerebellar maturation due to bleeding in the brain. By studying the role of fibrinogen, a protein involved in blood clotting, the research aims to identify potential therapeutic targets to prevent neurodevelopmental impairments. The approach includes using animal models to explore how fibrinogen affects neuroinflammation and brain repair processes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent developmental disabilities in preterm infants who experience brain hemorrhage.

How similar studies have gone: Other research has shown promising results in understanding the role of neuroinflammation in brain injuries, suggesting that this approach may yield significant insights.

Where this research is happening

  • University of California, San Francisco
    San Francisco, United States
    Active

Researchers

  • Principal investigator: Petersen, Mark a — University of California, San Francisco
  • Study coordinator: Petersen, Mark a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.